BioSpace News Archive

Business

Scientific Intake Names Two New Directors to its Board

Medical device and digital health company adds successful business veterans to team

July 11, 2018
·
3 min read
Drug Development

Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc. announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).

July 11, 2018
·
4 min read
Deals

Myovant Sciences Ltd. Announces $75 Million Public Offering of Common Shares

Myovant Sciences Ltd. announced that it has commenced an underwritten public offering of $75 million of its common shares.

July 11, 2018
·
3 min read
Business

Franciscan Health and William K. Payne M.D Receive Innovation Trailblazer Award for Adoption of New Navigation System for Hip Replacement Surgery

Dr. William Payne, local orthopedic surgeon, and Franciscan Health Olympia Fields, together, receive the Intellijoint Surgical Innovation Trailblazer Award of Excellence to acknowledge their adoption of intellijoint HIP

July 11, 2018
·
2 min read
Business

Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, August 8, 2018

Novanta Inc. will release its second quarter 2018 results on Wednesday, August 8, 2018.

July 11, 2018
·
1 min read
Policy

DUSA Pharmaceuticals, Inc. Files Lawsuit Against Biofrontera Inc. for Patent Infringement, Trade Secret Misappropriation, and Tortious Interference

The lawsuit alleges patent infringement of DUSA’s patents covering DUSA’s product for topical solution, 20% used with DUSA’s BLU-U Blue Light Photodynamic Therapy Illuminator.

July 11, 2018
·
2 min read
FDA

FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin

This is a co-formulation with Halozyme’s proprietary recombinant human hyaluronidase enzyme, which is approved and marketed under the Herceptin® SC brand in many countries outside the U.S.

July 11, 2018
·
3 min read
Business

BioCryst Provides Update on Strategy, Pipeline and Outlook

Provided an update on the Company’s strategic and financial outlook as a standalone company following the recent termination of its merger agreement with Idera Pharmaceuticals, Inc.

July 11, 2018
·
6 min read
Business

BioMarin to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2 at 4:30pm ET

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 2, at 4:30 p.m. ET

July 11, 2018
·
1 min read
Drug Development

BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia

The trial, which will be launched in the upcoming month, will be conducted in 25 medical centers in the US and Israel.

July 11, 2018
·
3 min read